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Abstract: A major limitation of using synthetic scaffolds in tissue engineering applications is insufficient angiogenesis
in scaffold interior. Bioactive borate glasses have been shown to promote angiogenesis. There is a need to investigate
the biofabrication of polymer composites by incorporating borate glass to increase the angiogenic capacity of the fabricated scaffolds. In this study, we investigated the bioprinting of human adipose stem cells (ASCs) with a polycaprolactone (PCL)/bioactive borate glass composite. Borate glass at the concentration of 10 to 50 weight %, was added to a
mixture of PCL and organic solvent to make an extrudable paste. ASCs suspended in Matrigel were ejected as droplets
using a second syringe. Scaffolds measuring 10 × 10 × 1 mm3 in overall dimensions with pore sizes ranging from 100 –
300 µm were fabricated. Degradation of the scaffolds in cell culture medium showed a controlled release of bioactive
glass for up to two weeks. The viability of ASCs printed on the scaffold was investigated during the same time period.
This 3D bioprinting method shows a high potential to create a bioactive, highly angiogenic three-dimensional environment required for complex and dynamic interactions that govern the cell’s behavior in vivo.
Keywords: Eioprinting, biofabrication, human adipose-derived stem cell, MSCs, bioactive glass, polycaprolactone,
scaffold, tissue engineering
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1. Introduction

D

ysfunctional or reduced blood supply is symptom of many health concerns, including diabetes, wound healing, and bone repair. Diabetes alone affects about 8.5% of the human population and costs the world over $376 billion in medical
related expenses each year[1]. Another problem associated with reduced blood supply exists in bone grafts.
Bone defects resulting from trauma, cancer, infection,

or congenital skeletal abnormalities contribute to
major surgeries performed every year. Autologous bone graft is still considered as the gold standard
for most applications but creates donor site morbidity[2,3]. Allografts avoid these issues but have limited
availability, concerns over immunogenicity, and potential disease transmission[4]. Several materials including biocompatible metals, bioceramics, and biopolymers are currently being investigated as candidates for synthetic grafts. Additive manufacturing

3D bioprinting of stem cells and polymer/bioactive glass composite scaffolds for bone tissue engineering. © 2017 Caroline Murphy, et al. This is an
Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is
properly cited.

53

3D bioprinting of stem cells and polymer/bioactive glass composite scaffolds for bone tissue engineering

(AM), or popularly known as 3D printing, is a
layer-by-layer material deposition process in which
functional parts with complex shapes can be made
which are otherwise difficult to manufacture. AM
of biomaterials has shown that complex and strong
implants can be made to treat different regions of bone,
including load-bearing bone[5–7]. However, engineered bone scaffolds have not been as successful as autologous grafts thus far, largely due to insufficient vascularization and reduced biomechanical function[8–9].
The choices of materials and fabrication process are
two significant factors that determine the success of
engineered scaffolds. Many synthetic polymers and
bioceramic materials have been used to make scaffolds for bone tissue engineering based on different
AM techniques[10,11]. Since polymers are only biocompatible, attempts have been made to improve
their bioactivity by adding different bioceramics to
make polymer composites. Typically, such composites
are prepared by mixing an inorganic bioceramic material (in particle or fiber form) with a polymer which
has been either heat melted or dissolved in an organic
solvent[12]. The bioactivity of the eventual composite
material not only depends on the choice of bioceramic
(including bioactive glass, hydroxyapatite, etc.) but
also depends on the method of composite preparation
itself. Composite foams and films made by traditional
fabrication methods such as solvent casting and particle leaching (SCPL) and thermally induced phase
separation (TIPS) have reported improved water absorption and formation of hydroxyapatite[13]. However,
it is difficult to control the scaffold porosity and shape
using such methods. Scaffolds made with AM techniques such as selective laser sintering and ink-jet
printing have also shown improved bioactivity, but
incorporating cells during fabrication akin to bioprinting is not feasible due to processing limitations.
3D bioprinting is a process that fabricates a “living”
construct in a layer-by-layer fashion using a “bio-ink”
(cells suspended in a medium) with or without additional materials. Creation of a 3D environment with
spatial arrangement of cells and materials is essential
for vascularization and complete implant integration
with the surrounding tissue. 3D bioprinting techniques
can be broadly classified into three categories: (i) laser-assisted[14,15], (ii) inkjet-based[16], and (iii) extrusion-based printing[17]. Extrusion-based 3D bioprinting is the most successful biofabrication process to
date with a range of materials compatible with the
process[17,18]. In an extrusion-based bioprinting pro54

cess, cells, hydrogels, and other materials are deposited using one or multiple syringes with a pressure
system. The pressure system consists of either a m echanical piston or a pneumatic pressure source (mostly compressed air) that is computer controlled. The
material is extruded through a nozzle tip and the process can deposit hydrogels with high cell density and
minimal wastage in comparison to laser-assisted and
ink-jet bioprinting techniques. Recent research has
focused on creating living or cell-laden grafts for tissues including bone, cartilage, and skeletal muscle[18–20]. In extrusion bioprinting, one syringe is typicallly devoted to melt the polymer and deposit the
melt for scaffolding structure. However, research to
date has only considered the melt-deposition process
to print scaffolding and is limited to low melting point
polymers. Therefore, it is essential to investigate alternate approaches for printing other materials in order to
develop more promising approaches in 3D bioprinting.
The addition of bioactive glass to a biocompatible
polymer transforms the 3D environment with its dissolution products by up-regulating the cell-cell and
cell-matrix interactions, which promotes vascularization. In the current study, we use a h ighly angiogenic bioactive 13-93B3 borate glass because of its osteo
stimulatory/conductive nature and anti-microbial properties[21]. In comparison to the more comm.on bioactive silicate glass, such as 45S5 or 13-93 glass, 1393B3 has a higher reaction rate (5–10 times faster than
silicate glasses) and resorbs (60 to 70% wt. loss) in a
few days to weeks[9]. Ion release from the borate glass
has been linked to the wound healing nature of this
glass, with the boron ions in particular leading to the
angiogenic effects, which are marginal in the silicate
glasses[22]. The borate glass was recently approved by
the Food and Drug Administration of the United
States for human use with trade name Mirragen™
Advanced Wound Matrix.
Mesenchymal stem/progenitor cells (MSCs) have been used for cell therapy and in tissue engineering because of their ability to differentiate into multiple mesenchymal lineages in vitro, immune modulatory effects, and angiogenic capacity[23,24]. MSCs have been
isolated from several tissues, including the bone marrow (BMSCs), adipose tissue (ASCs), and skin tissue[25–28]. The frequency of MSCs in adipose tissue is
much higher than the more commonly studied source
of bone marrow, yielding 100 to 500 times more cells
per tissue volume[29–30]. ASCs have similar self-renewal abilities, common surface epitopes, growth ki-
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netics, and cytokine expression profiles to BSCs. With
the addition of ASCs, the scaffold is expected to improve its biomechanical and biological properties
for better repair of the target tissue. In the current
study, we investigate the feasibility of scaffold fabrication using a two syringe system with a P CL/borate
glass composite dissolved in an organic solvent as a
scaffold material, whilst simultaneously printing cells
suspended in Matrigel, which is a gelatinous protein
mixture representing basement membrane. Included in
this study are the effect of borate glass content on the
composite paste printability, the scaffold temporal bioactivity, its degradation in culture media, and
ASC viability in the scaffold.

2. Materials and Methods
2.1 Preparation of PCL/13-93B3 Borate Glass
Composite Material
Polycaprolactone (Sigma-Aldrich, St. Louis, Missouri,
USA) was dissolved in chloroform (CF) (Sigma-Aldrich, St. Louis, Misouri, USA) in a covered glass container with the help of a stirrer at ~5 0°C.ThePCL
weight to CF volume ratio (grams:mL) was varied from
1:1 to 5:4 to determine the ideal ratio for printing. An
appropriate ratio was established by visually inspecting
the paste and through filament extrusion using a digital
syringe dispenser (Loctite®, Henkel North America,
Rocky Hill, Connecticut, USA). Then, 13-93B3 glass
(Mo-Sci Corporation, Rolla, Missouri, USA) (nominal
composition – 53% B2O3, 20% CaO, 12% K2O, 6%
Na2O, 5% MgO, 4% P2O5 in weight percentage) with
~20 µm particle size was added to the PCL:CF mix in
five different weight percentages in increments of 10,
ranging from 10% to 50%. A magnetic stirrer was used
to uniformly mix the composite paste, and no settling
of the glass particle precipitate was observed before
transferring the paste to a syringe. Each ratio was tested
using a digital syringe dispenser at air pressure ranging
from 10 to 50 psi and with nozzle tip diameter ranging
from 110 to 600 µm (32 G to 20 G).
2.2 Preparation of Bio-ink
Frozen vials of approximately 1 × 106 ASCs were obtained from three separate donors (LaCell, New Orleans, Louisiana, USA). Vials were unthawed, plated
on 150 cm2 culture dishes (Nunc, Rochester, New
York, USA) in 25 mL complete culture media (CCM),
and incubated at & with5%humidified CO2.The
CCM contained 10% fetal bovine serum (Corning,

Manassas, Virginia, USA), 1% 100× L-glutamine (GE
Life Sciences, Logan, Utah, USA), 2% 100× antibiotic/antimycotic (GE Life Sciences, Logan, Utah, USA,
and minimum essential medium alpha modified
(α-MEM) (Sigma-Aldrich, St. Louis, Missouri, USA).
After 24 hours, the media was removed and adherent,
viable cells were washed twice with PBS, harvested
with 0.25% trypsin/1mM EDTA (Gibco,Grand Island,
New York, USA), and replated at 100 cells/cm2 in
CCM. The media was changed every 3 to 4 days. For
all experiments, sub-confluent cells (≤70% confluent) between passages 2 and 6 were used. To prepare
the bio-ink, ASCs were suspended at a concentration of
10×106 cells per mL of Matrigel (Corning, Bedford,
Massachusetts, USA) diluted to 9 mg/mL in phosphate buffered saline (PBS). The bio-ink was then
transferred to a tap ered nozzle tip (30G) which was
stored on ice during the entire non-printing time.
The bio-ink was gently pipetted to obtain a uniform
distribution of cells just before printing. Matrigel was
used in this work as it resembles the complex extra
cellular environment found in many tissues.
2.3 Scaffold Fabrication
A square scaffold measuring 10 mm in length was
printed with 0°–90° orientation of the filaments in
alternate layers. The schematic in Figure 1A shows
the printing set-up and Figure 1B depicts the printing
process. A custom modified cartesian 3D printer
(Geeetech, Prusa I3 A Pro) with two additional syringes controlled by digital dispensers was used for
fabrication. The G-code for nozzle movement was
written to print in a 0°–90° pattern to obtain rectangular
pores. The printing parameters such as air pressure,
filament spacing, layer height, and printing speed were
identified based on visual inspection and optical microscopic images after the first and second layer
printing for different paste compositions. To determine
the printing parameters for Matrigel, an experiment
was conducted by varying the nozzle tip distance from
the glass slide, droplet dispensing time, and air pressure. Fluorescent images of the droplets were taken
and ImageJ software was utilized to quantify the
number of cells and cell distribution in each fluorescent image. A tapered nozzle tip (30 G) with 160 µm
orifice provided the suitable droplet size (~400 µm) at
10 psi and 0.035 s dispensing time for deposition on the
filament. While some droplets fell to the surrounding
pores, most of the droplets stayed on the filament before the Matrigel was allowed to cross-link at room
temperature. The fabrication experiments were
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Figure 1. (A) Schematic of the printing set-up. One syringe contained PCL, 13-93B3 glass, and chloroform, while the other syringe
contained ASCs suspended in Matrigel. (B) The composite layers are printed in 0o–90o pattern using one syringe while a second syringe prints the bio-ink droplets on top of every other layer.

performed at room temperature (64°F) where the variation in relative humidity (58–60%) was not considered to be a major factor.
2.4 Degradation of PCL/13-93B3 Glass Composite
The degradation of the PCL/13-93B3 composite was
studied on s caffolds measuring (10×10×1) mm3. The
printed scaffolds were dried at least for one day for
complete evaporation of CF. Before immersion, the
scaffolds were weighed and 300 mL of α-MEM was
used for 1 g of the scaffold for soaking. Scaffolds
were immersed in high density polyethylene (HDPE) bottles containing α-MEM and stored in an incubator maintained at 37°Cfor different time intervals
ranging from 1 da y to 14 days. After removal, the
scaffold was gently washed with de-ionized (DI) water,
and dried overnight. The dried scaffold was weighed
to calculate the weight loss percentage. A sample size
of three for each time interval was used in the study
and the results were reported as mean ± standard deviation.
2.5 Cell Viability and Proliferation
The effect of chloroform evaporation from the scaffold
on the viability of the ASCs was studied by depositing bio-ink droplets on the printed composite filaments.
For this study, three composite layers were printed on a
two-chamber microscope slide (Thermo Fischer
Scientific, Rochester, New York, USA) and allowed to
dry for ~2 mins before depositing a layer of bio-ink
droplets. The Matrigel in bio-ink was allowed to polymerize at r oom temperature for 20 minutes, then 1
mL of CCM was added. The slides were then incubated
at 37°Cwith5%humidified CO2 for three time intervals of 2 hrs, 1 week, and 2 weeks. The medium was
changed every three days. After each time interval, the
CCM was removed and the cells were stained using the
56

Live/Dead Cell Imaging Kit (ref. R37601, Eugene,
Oregon, USA), incubated for 15 minutes at room
temperature and examined under a fluorescent microscope (Olympus IX51, Melville, New York, USA).
2.6 Scaffold Characterization
Optical microscopic images were used to measure the
filament width and pore size with at least five measurements and the results were reported as mean ±
standard deviation. Samples were sputter coated with
gold/palladium (Au/Pd) for 60 s before performing
scanning electron microscopy (SEM). SEM (Hitachi
S-4700 FESEM, Hitachi Co., Tokyo, Japan) images
were taken to evaluate the surface morphology of the
scaffolds, internal structure of the filaments, and formation of hydroxyapatite-like material on the scaffold
surface. Scans were run from 2θ values ranging from
10° to 80° using Cu Kα radiation (λ = 0.154056 nm)
for X-ray diffraction (XRD) analysis (Philips X-Pert,
Westborough, MA) on the as-received PCL, as-printed
PCL/B3 glass scaffold, and the scaffold after α-MEM
immersion to determine the changes in the crystalline/amorphous nature of the material.

3. Results
3.1 Fabrication of PCL/13-93B3 Glass Composite
Scaffolds
The initial set of printing tests included depositing
single layers using the composite paste with 10 wt. %
of 13-93B3 glass. A minimum air pressure of 30 psi
was required to extrude the paste through a 260 μm
(25G) nozzle tip. Larger tips (>260 µm) resulted in
thick filaments which took longer time (>5 min) to dry
and smaller tips (<260 µm) consistently caused clogging issues. The roundness of the filament improved
with increasing glass content along with the paste
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viscosity. The minimum air pressure required to extrude the paste increased when glass content was increased from 10 wt. % to 30 wt. %. At higher glass
content (40 wt. % and 50 wt. %), the nozzle clogged
during fabrication. Therefore, additional CF (about 1
mL) was added to the paste to reduce the viscosity for
clog-free extrusion using the 25G tip. The 13-93B3
glass weight percentage and PCL: CF ratios used to
make composite pastes are shown in Table 1. The final printing parameters used to fabricate the composite scaffolds containing 50 wt. % 13-93B3 glass content is also provided in 7DEOH.
Table 1. PCL/13-93B3 glass paste compositions and printing
parameters
Composite 13-93B3 Glass
Paste #
(Zt. %)

PCL:CF
(g to mL)

Final Printing Parameters
(using C5 paste)

C1

10

5:3

Printing speed – 8 mm/s

C2

20

5:3

Dwell time – 2 min

C3

30

5:3

Layer height – 0.1 mm

C4

40

5:4

Air pressure – 30 psi

C5

50

5:4

Nozzle tip – 260 µm

A filament width of 397±10 μm was measured for
scaffolds printed with the C5 paste while average pore
size is dependent on the filament spacing. A filament
spacing of 600 µm provided square pores measuring
~160 µm (Figure 2A). In comparison, the average
pore size was ~350 µm for scaffolds fabricated with
800 µm filament spacing. Figure 2B shows scaffolds
fabricated with 800 µm filament spacing. Warping
was predominant while fabricating scaffolds with C1
and C2 pastes and this led to difficulty in printing after
about 8 l ayers; see warped C1 and C2 scaffolds in
Figure 2B. The warpage in scaffolds fabricated with
C3 paste was less pronounced and a scaffold height of
0.8 mm (10 layers) was obtained. Overall, the best
results were achieved for scaffolds fabricated with C5
paste as they were successfully printed to 1 mm height

(12 layers). The scaffold fabricated with C5 paste had
enough strength to be safely handled for subsequent
degradation and in vitro assessment.
SEM images of scaffolds fabricated with C5 paste
are shown in Figure 3. Figures 3A and 3B show the
surface morphology of the filament. Glass particles
are conspicuously absent from the surface of filaments.
No pores on the filament surface were detected even
when observed at a 2000× magnification. Figures 3C
and 3D show the filament cross-sectional surface.
Glass particles dispersed in the PCL matrix can be
seen in the interior. The dissolved PCL in chloroform
encloses the glass particles and surface tension effects between the nozzle tip and PCL during extrusion
appear to have caused the presence of only PCL on the
surface.
3.2 Degradation and Bioactivity of PCL/13-93B3
Glass Composite
Recent studies suggest that cell culture medium can be
used as an alternative to simulated body fluid (SBF) to
evaluate the bioactivity of the materials, with no significant differences in the formation of hydroxyapatite
(HA)[31]. We studied the degradation of the composite by soaking the scaffolds made with C5 paste in
α-MEM for 1, 3, 7, and 14 days. The scaffold
weight before and after immersion (post drying) was
recorded at each time interval. No significant weight
loss was observed for 3 days (less than 1%), and the
measured weight loss was 10.7±5% at 7 days and
23.2±4% at 14 days. As PCL takes a longer time to
degrade, the weight loss measured is due to the ionic
dissolution of the 13-93B3 borate glass. Formation of
flower like florets, which typically represent HA-like
material, was observed on the filament surface as
shown in Figures 4A and 4B.
The energy-dispersive X-ray spectroscopy (EDX)
analysis indicated the presence of calcium (Ca),
phosphorous (P), and oxygen (O) on the reacted

Figure 2. (A) Optical microscopic image showing the pores (~160 µm) in a composite scaffold fabricated with C5 paste. (B) Scaffolds
fabricated with different composite pastes (C1 to C5). The bottom panel shows scaffold warpage with an arrow indicating space between scaffold and slide. Warpage was minimal in C3/C4 scaffolds and completely absent in C5 scaffolds.
International Journal of Bioprinting (2017)–Volume 3, Issue 1
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Figure 3. SEM images of the 50:50 PCL/13-93B3 glass scaffold. (A) Low magnification (30×) image of scaffold surface showing
filaments and pores, (B) smooth surface morphology of filament (2000× magnified image of the region marked in (A), (C) fractured
surface of a broken filament with PCL matrix and glass particles, (D) magnified image of the region marked in (C) with arrows indicating glass particles present a few microns beneath the surface.

Figure 4. SEM images of the 50:50 PCL/13-93B3 glass scaffold after immersion in α-MEM for 14 days. (A) ~1 µm thick layer was
formed on the filament surface (a piece of the reacted layer indicated by arrow raised to expose the polymer beneath), (B) magnified
image (8000×) of the area marked in (A) showing the formation of HA-like florets on the filament.

surface of the scaffold after 14-day immersion in
α-MEM. Figure 5A shows the result of the line scan
performed on the surface indicating the changes in
elemental composition in atomic weight percentage.
In particular, carbon (C), Ca, P, and O are plotted to
provide a better comprehension of the reacted surface.
Signals of sodium (Na) and magnesium (Mg) were
also detected but in very small amounts. All the signals correspond to K series emissions (Kα and Kβ).
The location of the scan region is shown by an arrow
line in Figure 5B. The location was selected such that
a scan line (~70 µm long) has to start on a r eacted
surface, pass through the exposed PCL surface, and
end on the reacted surface. As signals were recorded,
the presence of elements was confirmed. It can be observed that the percentage of Ca and P drops to zero
58

and amount of O decreases as well when scanning the
PCL surface (from ~30 µm to ~50 µm in Figure 5A).
The presence of Ca, P, and O indicates that the glass
has reacted and formed HA-like material on the
scaffold surface.
3.3 Effect of Chloroform Evaporation on ASC
Viability
The viability of ASCs was studied by performing a
live/dead assay after incubating the samples for 24
hours, and 1 week. The viability of cells after 24 hours
was 70±10% (Figures 6A and 6B). After 1 week, the
viability of cells was 58±11% (Figures 6C and 6D).

4. Discussion
A variety of solvents are available to dissolve different
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Figure 5. EDX analysis on the surface of the 50:50 PCL/13-93B3 glass scaffold soaked in α-MEM. (A) Graph of line scan data
showing the variation in Ca, P, O, and C in atomic weight percentages; presence of Ca, P, and O on the reacted surface confirms the
glass reaction and formation of HA-like material, (B) SEM image with the arrow line indicating the scanned area for EDX analysis.

Figure 6. Live/Dead images of ASCs suspended in Matrigel and printed on the 50:50 PCL/13-93B3 glass composite scaffold. Imaged after (A–B) 24 hours, and (C–D) 1 week. The dotted lines indicate the outline of the filament and dark space indicates the pore.

biopolymers[32]. Extrusion of solvent dissolved polymer and bioactive glass is safe at r oom temperature
and reduces the process complexity since there is no
need for temperature control. This method can be
adopted by most of the existing open-source 3D printers available in the market. Chloroform (CF) was
used in this study because it provides: (i) a h igh viscosity paste, making it suitable for extrusion-based 3D
printing, (ii) fast evaporation (~2 min), making it safe
to print ASCs in Matrigel during the fabrication
process, (iii) filament porosity for accelerated glass
dissolution to the surrounding, and (iv) faster polymer bulk degradation by exposing the interior of filament. To address the issue of safety with the use of CF
while depositing bio-ink, we performed cell viability
study on scaffolds made with C3 (30% glass) and C5

(50% glass) composite pastes using a live/dead assay.
The results showed healthy living A SCs on P CL/1393B3 glass filaments even after one week of incubation.
An important aspect in extrusion bioprinting is to
create a scaffolding structure that supports cells and
provides shape and mechanical integrity. Extrusion bioprinters typically have more than one syringe,
with one of the syringes devoted to print scaffolding
structure. The options utilized for this purpose include
melt-deposition of polymer and fused deposition
modeling (FDM) with a polymer wire feed. Because
of high temperatures involved in many melting biopolymers such as polylactic acid (PLA, with a melting
point of 160°C), PCL has become one of the most
widely used polymers owing to its lower melting point
of 60 °C. For 3D printing, PCL is an attractive op-
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tion because of its good rheological and viscoelastic
properties. Despite its slow degradation rate (~2 years
depending on the molecular weight), PCL has been
widely used to fabricate scaffolds for bone tissue engineering[33]. But for other tissue engineering applications which require faster degrading of scaffolding
structure, this may become an impediment. Since
FDM fabricated polymer scaffolds are only biocompatible, another issue would be to make the scaffolding structure bioactive by incorporating bioceramic
materials. In the past, some researchers made a polymer-bioactive glass wire for use by the FDM process
to fabricate polymer-bioactive glass scaffolds[34].
However, no significant improvement in bioactivity
and cell growth has been reported, which could be due
to inadequate ionic dissolution of the glass into the
surrounding environment. This makes the FDM and
melt-deposition options unattractive for fabrication of
polymer-glass composite scaffolds. In our current
study, polymer (PCL) was dissolved in a s olvent
(chloroform), mixed with a bioactive glass (13-93B3
glass), and then extruded to fabricate the scaffold. Our
weight loss results showed that most of the 13-93B3
glass has reacted in 2 weeks. The schematic in Figure 7 explains the difference in the glass dissolution
from filaments printed using (A) FDM or melt-extrusion process and (B) solvent-based extrusion process.

Fine cracks on the filament surface which are a couple
of microns wide and up to ten microns or more in
length can be observed in Figure 7C. Those cracks
are believed to aid glass dissolution when the scaffold
is immersed in the culture medium.
Our degradation results also show a controlled release of 13-93B3 glass over a period of two weeks
into the surrounding solution. In the past, composite
thin films have been made using PCL/13-93B3 glass
and PCL/45S5 glass with different amount of glass
content[35]. The degradation data of such thin films
indicate that the entire glass almost completely dissolves in about three days. The graph shown in Figure
8 compares the weight loss percentage of the
PCL/13-93B3 glass thin films (80 µm) with that of the
current study. Almost entire 13-93B3 glass was
reacted in about 3 da ys from thin films. The faster
degradation in composite films could be due to the
thickness of the film. The scaffolds in the current
study are made by filaments which are about 400 µm
in diameter and have no surface pores that explained
the very little glass dissolution in three days. However,
the water absorbing potential of polymers in general
was reportedly found to improve after the addition
of bioceramic filler materials such as HA and even bioactive glass[12]. In our study, the glass dissolution increased significantly after 7 and 14 days, which is

Figure 7. Schematic highlighting the difference in two methods of extrusion printing. (A) Melt-deposition of polymer-glass composite resulting in a dense filament and low bioactivity, (B) solvent-based extrusion printed composite resulting in a porous filament
with high bioactivity, (C) SEM images showing surface cracks on the filament indicated by arrows in (i) and (ii), and pores inside the
filament measuring less than 10 µm are also indicated by arrows in (iii).
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believed to be due to the internal porosity of the filament created after the CF evaporation and also glass
dissolution creating more porosity. The entire B2O3
present in the borate glass (53 B2O3, 20 CaO, 12 K2O,
6 Na2O, 5 MgO, 4 P2O5 in composition by w eight %)
completely dissolves into surrounding environment,
and the rest oxides with the exception of MgO participate in the formation of HA. By neglecting the
weight of HA formed, it can be theoretically calculated that there is about ~35% weight loss for the
scaffold, assuming a complete 13-93B3 glass dissolution in 50:50 PCL/13-93B3 composite. In this study,
the weight loss for 50:50 PCL/13-93B3 compositescaffold was ~23%, indicating that ~70% of the 13-93B3
glass present in the scaffold had reacted in 14 days.
This degradation vs. time characteristic can be used to
develop a controlled degradation of 3D scaffold that
is beneficial in certain tissue engineering applications,
especially in drug delivery.

Figure 8. Weight loss percentage comparison of 3D printed
50:50 PCL/13-93B3 glass composite scaffolds vs. thin film
composite made using PCL, CF, and 50% 13-93B3 glass[35].

The reacted layer formed on the scaffold surface
was ~1 µm thick and not completely uniform (dense
collection of florets can be seen in Figure 4C). XRD
analysis was performed to confirm the presence of
crystalline HA but the XRD pattern obtained on a 14
day soaked scaffold could not match the known HA
crystalline peak. This is believed to be because of
formation of amorphous HA or non-stoichiometric
HA, which is not uncommon in such cases. Figure 9
shows XRD patterns of the as-received 13-93B3 glass,
PCL/13-93B3 glass composite scaffold, and the composite scaffold after soaking in α-MEM for 2 weeks.
The semi-crystalline nature of the PCL was confirmed
with characteristic peaks (marked by *) and amorph-

ous profile of 13-93B3 glass with no sharp peaks and
characteristic hump can be observed in the XRD patterns shown in Figure 9. There are additional peaks
observed for the α-MEM soaked sample which could
not be identified to a known material in the database
(marked by †). However, the typical amorphous hump
seen in glass was not existent in the soaked sample,
indicating that most of the 13-93B3 glass in the scaffold has reacted after 14 days.

Figure 9. XRD patterns of (A) 50:50 PCL/13-93B3 glass
composite scaffold soaked in α-MEM for 14 days, (B)
PCL/13-93B3 glass scaffold, (C) as-received PCL showing a
semi-crystalline nature with characteristic peaks marked by *,
and (D) as-received 13-93B3 glass with characteristic amorphous hump (25° to 35° and 40° to 50°).

It is known that pore size is an important parameter
of the scaffold that could potentially affect the bone
growth after implantation, and it has been reported
that pore size in the range of 100 to 300 µm is beneficial for bone growth[9]. The scaffolds we fabricated
have pores in this range. Moreover, the ASCs when
co-cultured with 2.5 mg of 13-93B3 glass per 1 mL of
culture media in standard culture conditions show osteogenic differentiation with no detrimental effects.
Therefore, the scaffolds fabricated using solvent-based
extrusion 3D bioprinting developed as in the present
study have a high potential for non-load-bearing bone
repair applications.
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4.

5. Conclusion
This study investigated the feasibility of fabricating a
scaffold with polycaprolactone/bioactive borate glass
composite using a solvent based extrusion 3D printer
integrated with printing of human ASCs suspended in
Matrigel during the scaffold fabrication process.
Printing process parameters were identified for the
composite and bio-ink to fabricate a (10×10×1) mm3
ASC-laden scaffold with pore sizes ranging from 100
to 300 µm suitable for bone tissue engineering. In
comparison to the conventional melt-deposition extrusion 3D bioprinting, the degradation of polymer/bioactive glass scaffolds showed a c ontrolled release
of bioactive glass with ~23% weight loss in two
weeks. Formation of hydroxyapatite-like crystals on
the surface of the scaffold after soaking in culture media for up to two weeks shows the strong bioactivity
of the fabricated composite scaffold and its high potential for bone repair. The live/dead assay showed
more than 60% viable ASCs on the scaffold after 1
week of incubation, with minimal negative effects
from chloroform evaporation on the cells. The results
of this study show the high potential of the solvent-based extrusion 3D bioprinting process to fabricate a scaffold with cells and polymer composites for
tissue engineering applications.
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